An Open Trial Examining the Relationship Between the Frequency of Everyday Behaviours and Mental Health Before and During Treatment - the Wellbeing Course

Not Applicable

Completed

• Conditions: Anxiety; Depression; Mental Health - Anxiety; Mental Health - Depression

• Registration Number: ACTRN12618001585213
• Lead Sponsor: Macquarie University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-25
• Study Completion: 2020-02-06
• Last Update Posted: 5 July 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 434

Inclusion Criteria

(a) Aged 18 years or older;
(b) Living in Australia; and
(c) Experiencing at least mild symptoms of general anxiety and/or depression (indicated by a total score of at least 5 on the Generalized Anxiety Disorder-7 (GAD-7) and/or the Patient Health Questionnaire-9 (PHQ-9)).

Exclusion Criteria

(a) Very severe depression (i.e., indicated by a score > 25 on the PHQ-9)
(b) Acutely suicidal or recent history of attempted suicide (i.e., last 12 months)
(c) A primary problem that is not anxiety or depression (e.g., psychosis, substance abuse)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient Health Questionnaire 9-Item (PHQ9), which is a measure of depression. [The PHQ9 will be administered at assessment, pre-treatment, fortnightly throughout treatment, and 8 weeks post-treatment. Post-treatment is the primary timepoint.];Generalized Anxiety Disorder 7-Item (GAD7), which is a measure of anxiety.[The GAD7 will be administered at assessment, pre-treatment, fortnightly throughout treatment, and 8 weeks post-treatment. Post-treatment is the primary timepoint.];The Things You Do Questionnaire (TYDQ), which is a purpose built measure of everyday behaviours developed by the research team. It contains 60 items.[The TYDQ will be administered at assessment, pre-treatment, fortnightly throughout treatment, and 8 weeks post-treatment. Post-treatment is the primary timepoint.]

Secondary Outcome Measures

Name	Time	Method
Treatment credibility and expectancy questionnaire (CEQ), which is a 6 item measure designed to measure expectations of treatment outcome.[The CEQ will be administered at pre-treatment only.];Satisfaction With Life Scale (SWLS) is a 5 item measure of satisfaction with and quality of life.[The SWLS will be administered at pre-treatment and 8 weeks post-treatment. ];The Brief Five Inventory 10-item (BFI-10) is a 10 item scale designed to measure the big 5 personality traits.[The BFI-10 will be administered at assessment, pre-treatment and 8 weeks post-treatment. ]